Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-08-18Clinical Trial Update: A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder [Phase 2, Phase 3]
A Phase 2/3 pediatric ADHD trial conducted by Eli Lilly has completed and posted results (results posted 2014-08-18).
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: OROS Methylphenidate (Concerta) in the Treatment of Adult ADHD [Phase 2, Phase 3]
Completed Phase 2/3 trial update evaluating OROS methylphenidate (Concerta) for adult attention deficit hyperactivity disorder.
-
CLINICAL_TRIALS trial_result · 2014-08-11Clinical Trial Update: Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia [Phase 4]
Phase 4 trial evaluating guanfacine extended-release for ADHD-associated insomnia was terminated; results were posted in 2014.
-
CLINICAL_TRIALS research · 2014-07-29Clinical Trial Update: Adults With Attention Deficit Hyperactivity Disorder (ADHD): Validation of a Clinical Interview and Screening Instruments in French [NA]
This completed study validates a clinical interview and French-language screening instruments for adults with Attention Deficit Hyperactivit…
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: Inuniv and Working Memory [Phase 4]
Phase 4 trial update notes completion of a study evaluating Inuniv (guanfacine) and working memory in Attention Deficit Hyperactivity Disord…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-07-24FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for a product containing dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine …
-
CLINICAL_TRIALS research · 2014-07-21Clinical Trial Update: Cost-Effectiveness Study Of The Treatment Of Attention Deficit/Hyperactivity Disorder In Brazil [Phase 4]
Phase 4 cost-effectiveness study evaluating ADHD treatment in Brazil has been completed.
-
FDA approval · 2014-07-18FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) submitted by Takeda Pharmaceuticals America, Inc. The acti…
-
FDA label_change · 2014-07-14FDA Approved: RITALIN — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for RITALIN (methylphenidate hydrochloride) filed by Novartis Pharmaceuticals Corporation, resul…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 3]
Phase 3 trial update evaluating the efficacy and safety of extended-release guanfacine hydrochloride for children and adolescents with ADHD;…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Quillivant Oral Suspension (Quillivant XR) in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) [Phase 3]
Pfizer's Quillivant XR (methylphenidate extended-release) completed a Phase 3 trial for attention-deficit/hyperactivity disorder. Results we…
-
CLINICAL_TRIALS research · 2014-06-26Clinical Trial Update: Self-help in Adjunct to Pharmacotherapy [NA]
Clinical trial update from the University of Nottingham evaluating self-help as an adjunct to pharmacotherapy for Attention-Deficit/Hyperact…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: CBT Group for Adolescents With ADHD: a Randomized Controlled Trial [NA]
This update reports results from a randomized controlled trial evaluating a cognitive-behavioral therapy group for adolescents with attentio…
-
CLINICAL_TRIALS trial_result · 2014-06-13Clinical Trial Update: Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance? [Phase 4]
Phase 4 clinical trial update evaluating whether pharmacological treatment of Attention-Deficit/Hyperactivity Disorder in adults improves pa…
-
FDA approval · 2014-06-10FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Teva's generic fixed-dose combination of amphetamine salts (dextroamphetamine saccharate, amphet…
-
CLINICAL_TRIALS trial_result · 2014-06-09Clinical Trial Update: Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) [Phase 3]
Phase 3 trial update on maintenance of efficacy for extended-release guanfacine hydrochloride in children and adolescents with ADHD.
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: Non-pharmacological Interventions for Preschoolers With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 2]
Phase 2 study evaluating non-pharmacological interventions for preschool children with Attention Deficit Hyperactivity Disorder has complete…
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: School-Based Mental Health Services for Urban Children [NA]
A school-based mental health services trial for urban children has completed enrollment, focusing on conditions including conduct disorder, …
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Effect of Working Memory Training on ADHD Brain Function [Phase 3]
Phase 3 trial evaluating whether working memory training affects brain function in Attention-Deficit/Hyperactivity Disorder (combined subtyp…
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: Exploring the Group Visit Model for Pediatric ADHD Management in the Medical Home [NA]
This update reports on a completed clinical trial from Indiana University evaluating a group visit model for managing attention-deficit/hype…
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder [Phase 1]
A Phase 1 clinical trial update reports on evaluating cognitive behavioral therapy for adults with attention-deficit/hyperactivity disorder …
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: Open-label Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder [Phase 3]
Open-label extension study of methylphenidate hydrochloride extended-release in adults with ADHD; results from a Phase 3 trial have been pos…
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl [Phase 3]
Phase 3 dose-optimization trial in adolescents (13-17) with ADHD evaluating extended-release guanfacine HCl; study completed with posted res…
-
FDA approval · 2014-05-19FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's generic dexmethylphenidate hydrochloride under an original ANDA, expanding treatment options for attention-deficit/hyper…
-
FDA approval · 2014-05-19FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Original Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's generic dexmethylphenidate hydrochloride under an original ANDA (ANDA 078908) for the treatment of attention-deficit…